Monday, April 21, 2025 | 05:15 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Piramal Pharma Share Price

Know More
BSENSE

201.25 10.75 (5.64%)

16:01 PM, 12-Mar-2025
Stock not traded

BSE : 543635

NSE : PPLPHARMA

Sector : Health care

ISIN Code : INE0DK501011

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 12-Mar-2025 | 04:01 PM IST

Market Cap (₹ Cr)

26,681

Traded Value (₹ Cr)

8.80

Volume (Shares)

4,37,361

Face Value (₹)

10

52-Week High (₹)

307.85

52-Week High Date

06-Nov-2024

52-Week Low (₹)

132.05

52-Week Low Date

15-Apr-2024

All Time High (₹)

307.85

All Time High Date

06-Nov-2024

All Time Low (₹)

61.65

All Time Low Date

28-Mar-2023

Piramal Pharma Ltd

Piramal Pharma Limited was incorporated on March 4 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes an integrated CDMO busi...
Read More

Piramal Pharma Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

26,681

EPS - TTM (₹) [C]

0.40

P/E Ratio (X) [C]

503.13

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) 0.05
Book Value Share (₹) [C]59.66
P/B Ratio (₹) [C]3.37

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
HDFC Flexi Cap Fund - (IDCW) 1542.15 8,12,12,856 2.40
HDFC Flexi Cap Fund - (G) 1542.15 8,12,12,856 2.40
HDFC Flexi Cap Fund - Direct (IDCW) 1542.15 8,12,12,856 2.40
HDFC Flexi Cap Fund - Direct (G) 1542.15 8,12,12,856 2.40
HDFC Focused 30 Fund (G) 436.75 2,30,00,000 2.81
HDFC Focused 30 Fund (IDCW) 436.75 2,30,00,000 2.81
HDFC Focused 30 Fund - Direct (IDCW) 436.75 2,30,00,000 2.81
HDFC Focused 30 Fund - Direct (G) 436.75 2,30,00,000 2.81
Franklin India Opportunities Fund - (G) 64.71 34,07,626 1.17
Franklin India Opportunities Fund - Direct (G) 64.71 34,07,626 1.17

Load more

Research Reports

DateBrokerActionPrices(₹) Report
25-Sep-2024Motilal Oswal Buy -

Stock Strength

Today's Low/High (₹)

193.30

205.20

Week Low/High (₹)

99.15

205.20

Month Low/High (₹)

99.15

205.20

Year Low/High (₹)

132.05

308.00

All time Low/High (₹)

61.65

308.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week95.58%96.23%22.97%27.64%
1 Month62.30%62.89%19.03%23.24%
3 Month14.90%15.33%19.93%24.47%
6 Month--25.04%29.23%
1 Year--24.11%27.96%
3 Year--82.98%91.93%

Company Info

Company Information

Registered Office: Ground Floor Piramal Ananta, Agastya Corp.Park LBS MargKurl,Mumbai,Maharashtra-400070 Ph: 91-22-3802-3000/4000

Email:corporate.secretarial@piramal.com

URL:http://www.piramal.com

FAQs about Piramal Pharma Ltd

1. What's the Piramal Pharma Ltd share price today?
Piramal Pharma Ltd share price was Rs 201.25 at 16:01 PM IST on 12th Mar 2025. Piramal Pharma Ltd share price was up by 5.64% over the previous closing price of Rs 190.50. Piramal Pharma Ltd share price trend:

  • Last 1 Month: Piramal Pharma Ltd share price moved up by 62.30% on BSE.
  • Last 3 Months: Piramal Pharma Ltd share price moved up by 14.90% on BSE.


2. How can I quickly analyse the performance of the Piramal Pharma Ltd stock?
The performance of the Piramal Pharma Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 503.13
  • Price to book value ratio is 3.37
  • Dividend yield of 0.05
  • The EPS (trailing 12 months) of the Piramal Pharma Ltd stock is Rs 0.40


3. What is the market cap of Piramal Pharma Ltd?
Piramal Pharma Ltd has a market capitalisation of Rs 26,681 crore.


4. What is Piramal Pharma Ltd's 52-week high/low share price?
The Piramal Pharma Ltd’s 52-week high share price is Rs 307.85 and 52-week low share price is Rs 132.05.


5. Is the Piramal Pharma Ltd profitable?
On a consolidated basis, Piramal Pharma Ltd reported a profit of Rs 3.68 crore on a total income of Rs 2,233.40 crore for the quarter ended 2024. For the year ended 2024, Piramal Pharma Ltd had posted a profit of Rs 17.82 crore on a total income of Rs 8,171.16 crore.


6. Which are Piramal Pharma Ltd’s peers in the Health care sector?
Piramal Pharma Ltd’s top 5 peers in the Health care sector are Ajanta Pharma, Laurus Labs, Suven Pharma, Piramal Pharma, Gland Pharma, J B Chemicals &, Wockhardt.


7. Who owns how much in Piramal Pharma Ltd?
Key changes to the Piramal Pharma Ltd shareholding are as follows:

  • Promoter holding in Piramal Pharma Ltd has gone up to 34.79 per cent as of Dec 2022 from 34.79 per cent as of Sep 2022.